Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Russo

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Medical Research and Opinion|October 7, 2011
Adult ADHD: prevalence of diagnosis in a US population with employer health insuranceLeslie Montejano, Rahul Sasané, Paul Hodgkins, et al.
Clinical Therapeutics|May 4, 2016
Corrigendum to "Descriptive Comparison of Drug Treatment-Persistent, - Nonpersistent, and Nondrug Treatment Patients With Newly Diagnosed Attention Deficit/Hyperactivity Disorder in Germany" Clin Ther 2013;35:673-685Sebastian Braun, Leo Russo, Jan Zeidler, et al.
Clinical Therapeutics|April 17, 2013
Descriptive comparison of drug treatment-persistent, -nonpersistent, and nondrug treatment patients with newly diagnosed attention deficit/hyperactivity disorder in GermanySebastian Braun, Leo Russo, Jan Zeidler, et al.
Clinical Pharmacology and Therapeutics|November 28, 2021
Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial DesignSimon Dagenais, Leo Russo, Ann Madsen, et al.
Urologic Oncology|July 28, 2024
Factors associated with receipt of systemic anticancer treatment for locally advanced or metastatic urothelial carcinoma in England: a population-based studySeyed Hamidreza Mahmoudpour, Craig Knott, Mairead Kearney, et al.
European Journal of Clinical Pharmacology|March 11, 2014
Role of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazineLeo Russo, Gary Schneider, Margarita Hauser Gardiner, et al.
Journal of Attention Disorders|August 1, 2013
Nonmedical use of prescription ADHD stimulant medications among adults in a substance abuse treatment population: early findings from the NAVIPPRO surveillance systemTheresa A Cassidy, Emily C McNaughton, Sajan Varughese, et al.
Drug Safety|August 19, 2008
A model for decision support in signal triageBennett Levitan, Chuen L Yee, Leo Russo, et al.
Journal of Attention Disorders|December 28, 2012
Nonmedical Use and Diversion of ADHD Stimulants Among U.S. Adults Ages 18-49: A National Internet SurveyTheresa A Cassidy, Sajan Varughese, Leo Russo, et al.
British Journal of Clinical Pharmacology|March 12, 2022
Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritisJonathan Mauer, Kristin Bullok, Stephen Watt, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Medical Research and Opinion|October 7, 2011
Adult ADHD: prevalence of diagnosis in a US population with employer health insuranceLeslie Montejano, Rahul Sasané, Paul Hodgkins, et al.
Clinical Therapeutics|May 4, 2016
Corrigendum to "Descriptive Comparison of Drug Treatment-Persistent, - Nonpersistent, and Nondrug Treatment Patients With Newly Diagnosed Attention Deficit/Hyperactivity Disorder in Germany" Clin Ther 2013;35:673-685Sebastian Braun, Leo Russo, Jan Zeidler, et al.
Clinical Therapeutics|April 17, 2013
Descriptive comparison of drug treatment-persistent, -nonpersistent, and nondrug treatment patients with newly diagnosed attention deficit/hyperactivity disorder in GermanySebastian Braun, Leo Russo, Jan Zeidler, et al.
Clinical Pharmacology and Therapeutics|November 28, 2021
Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial DesignSimon Dagenais, Leo Russo, Ann Madsen, et al.
Urologic Oncology|July 28, 2024
Factors associated with receipt of systemic anticancer treatment for locally advanced or metastatic urothelial carcinoma in England: a population-based studySeyed Hamidreza Mahmoudpour, Craig Knott, Mairead Kearney, et al.
European Journal of Clinical Pharmacology|March 11, 2014
Role of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazineLeo Russo, Gary Schneider, Margarita Hauser Gardiner, et al.
Journal of Attention Disorders|August 1, 2013
Nonmedical use of prescription ADHD stimulant medications among adults in a substance abuse treatment population: early findings from the NAVIPPRO surveillance systemTheresa A Cassidy, Emily C McNaughton, Sajan Varughese, et al.
Drug Safety|August 19, 2008
A model for decision support in signal triageBennett Levitan, Chuen L Yee, Leo Russo, et al.
Journal of Attention Disorders|December 28, 2012
Nonmedical Use and Diversion of ADHD Stimulants Among U.S. Adults Ages 18-49: A National Internet SurveyTheresa A Cassidy, Sajan Varughese, Leo Russo, et al.
British Journal of Clinical Pharmacology|March 12, 2022
Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritisJonathan Mauer, Kristin Bullok, Stephen Watt, et al.
Pageof 3